降钙素原在慢性阻塞性肺疾病急性加重期指导抗生素使用的价值

The value of procalcitonin in guiding antibiotic therapy for acute exacerbation of chronic obstructive pulmonary disease

目的:探讨降钙素原(PCT)在慢性阻塞性肺疾病急性加重期(AECOPD)指导抗生素使用的临床价值。方法:收集134例AECOPD患者,随机分为PCT组(47例)、指南组(42例)和经验组(45例),对3组患者临床有效率、医疗总费用、抗生素使用费用、住院天数进行统计学评价。结果:PCT组与指南组在医疗总费用、抗生素使用费用、住院天数上差异均无统计学意义(P>0.05),PCT组和指南组在医疗总费用、抗生素使用费用、住院天数分别与经验组比较差异均有统计学意义(均P<0.05),3组治疗有效率比较差异无统计学意义(P>0.05)。结论:在AECOPD抗感染治疗情况下,利用PCT检测指导抗生素使用能够有效减少住院总费用、抗生素使用费用并缩短患者住院时间。

Objective： To investigate the value of procalcitonin（PCT） in guiding antibiotic therapy for acute exacerbation of chronic obstructive pulmonary disease（AECOPD）. Methods： Totally 134 patients with AECOPD were randomly divided into PCT group（47 cases）, Guide group（42 cases） and Experience group（45 cases）. Three groups of clinical effi cacy, the total medical costs, costs of antibiotic therapy and hospitalization days were statistically analysed. Results： Between the PCT group and the guide group in the total medical costs, costs of antibiotics and hospitalization days had no statistically signifi cant difference（P〈0.05）. PCT group and guide group in the total medical costs, costs of antibiotics and hospitalization days were statistically signifi cant difference compared with the experience group（P〈0.05）. There was no signifi cant diference in cases of clinical effi cacy among the three groups（P〉0.05）. Conclusion： PCT detection can effectively reduce the total costs of hospitalization, which can also reduce costs of antibiotic therapy and the duration of hospital stay in the treatment of AECOPD patients.